243 related articles for article (PubMed ID: 28326633)
1. Bias from depletion of susceptibles: the example of hormone replacement therapy and the risk of venous thromboembolism.
Renoux C; Dell'Aniello S; Brenner B; Suissa S
Pharmacoepidemiol Drug Saf; 2017 May; 26(5):554-560. PubMed ID: 28326633
[TBL] [Abstract][Full Text] [Related]
2. Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration.
Bergendal A; Kieler H; Sundström A; Hirschberg AL; Kocoska-Maras L
Menopause; 2016 Jun; 23(6):593-9. PubMed ID: 27023862
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy and the risk of venous thromboembolism: a population-based study.
Renoux C; Dell'Aniello S; Suissa S
J Thromb Haemost; 2010 May; 8(5):979-86. PubMed ID: 20230416
[TBL] [Abstract][Full Text] [Related]
4. Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal estrogen meta-analysis.
Scarabin PY
Climacteric; 2018 Aug; 21(4):341-345. PubMed ID: 29570359
[TBL] [Abstract][Full Text] [Related]
5. Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis.
Rovinski D; Ramos RB; Fighera TM; Casanova GK; Spritzer PM
Thromb Res; 2018 Aug; 168():83-95. PubMed ID: 29936403
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study.
Sweetland S; Beral V; Balkwill A; Liu B; Benson VS; Canonico M; Green J; Reeves GK;
J Thromb Haemost; 2012 Nov; 10(11):2277-86. PubMed ID: 22963114
[TBL] [Abstract][Full Text] [Related]
7. Hormones and venous thromboembolism among postmenopausal women.
Scarabin PY
Climacteric; 2014 Dec; 17 Suppl 2():34-7. PubMed ID: 25223916
[TBL] [Abstract][Full Text] [Related]
8. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.
Canonico M; Oger E; Plu-Bureau G; Conard J; Meyer G; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
Circulation; 2007 Feb; 115(7):840-5. PubMed ID: 17309934
[TBL] [Abstract][Full Text] [Related]
9. Hormone therapy and risk of venous thromboembolism among postmenopausal women.
Canonico M
Maturitas; 2015 Nov; 82(3):304-7. PubMed ID: 26276103
[TBL] [Abstract][Full Text] [Related]
10. Transdermal hormone therapy and the risk of stroke and venous thrombosis.
Speroff L
Climacteric; 2010 Oct; 13(5):429-32. PubMed ID: 20670199
[TBL] [Abstract][Full Text] [Related]
11. Concurrent use of statins and hormone therapy and risk of venous thromboembolism in postmenopausal women: a population-based case-control study.
Fournier JP; Duijnhoven RG; Renoux C; Dell'Aniello S; Klungel OH; Suissa S
Menopause; 2014 Sep; 21(9):1023-6. PubMed ID: 24937027
[TBL] [Abstract][Full Text] [Related]
12. Hormone therapy and venous thromboembolism among postmenopausal women.
Scarabin PY
Front Horm Res; 2014; 43():21-32. PubMed ID: 24943295
[TBL] [Abstract][Full Text] [Related]
13. [Hormone replacement therapy and venous thromboembolism].
Pavičić Baldani D; Skrgatić L; Simunić V; Elvedi Gasparović V; Geršak B
Lijec Vjesn; 2015; 137(1-2):34-40. PubMed ID: 25906547
[TBL] [Abstract][Full Text] [Related]
14. Effect of NFE2L2 genetic polymorphism on the association between oral estrogen therapy and the risk of venous thromboembolism in postmenopausal women.
Bouligand J; Cabaret O; Canonico M; Verstuyft C; Dubert L; Becquemont L; Guiochon-Mantel A; Scarabin PY;
Clin Pharmacol Ther; 2011 Jan; 89(1):60-4. PubMed ID: 21107315
[TBL] [Abstract][Full Text] [Related]
15. Estrogen and progestogen effect on venous thromboembolism in menopausal women.
Archer DF; Oger E
Climacteric; 2012 Jun; 15(3):235-40. PubMed ID: 22612609
[TBL] [Abstract][Full Text] [Related]
16. Hormone therapy and recurrence of venous thromboembolism among postmenopausal women.
Olié V; Plu-Bureau G; Conard J; Horellou MH; Canonico M; Scarabin PY
Menopause; 2011 May; 18(5):488-93. PubMed ID: 21178641
[TBL] [Abstract][Full Text] [Related]
17. [Basic principles of hormone replacement therapy in the postmenopause].
Dören M
Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
[TBL] [Abstract][Full Text] [Related]
18. Hormone therapy and risk of venous thromboembolism among postmenopausal women.
Canonico M; Scarabin PY
Climacteric; 2009; 12 Suppl 1():76-80. PubMed ID: 19811247
[TBL] [Abstract][Full Text] [Related]
19. Increased thrombin generation among postmenopausal women using hormone therapy: importance of the route of estrogen administration and progestogens.
Scarabin PY; Hemker HC; Clément C; Soisson V; Alhenc-Gelas M
Menopause; 2011 Aug; 18(8):873-9. PubMed ID: 21487317
[TBL] [Abstract][Full Text] [Related]
20. Synergism between oral estrogen therapy and cytochrome P450 3A5*1 allele on the risk of venous thromboembolism among postmenopausal women.
Canonico M; Bouaziz E; Carcaillon L; Verstuyft C; Guiochon-Mantel A; Becquemont L; Scarabin PY;
J Clin Endocrinol Metab; 2008 Aug; 93(8):3082-7. PubMed ID: 18628519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
